Rick,
">> Not a fair comparison, really, as I got to average in <<
There were a few communication glitches, given a history of relatively unmanaged portfolios in the birthplace of "trickle". But it's great to see a second effort at SI biotech like that of VDXX.
Journalists will rip you off, right and left. This is a very good thing."
Speaking of unfair comparisons, V1 is one of the folks I respect most here at SI, and his portfolio is arguably one of the most successful here, given its age. I take some comfort in noting that both he and I more or less independently arrived at a secondary buy target of 25 for INCY. Invited him to stop by here, and he said he'd bookmarked it. That was in the beginning. Think I should follow my shot?
As for journalists ripping me off, I guess worse things could happen. I'd be flattered and it ought to help Trickle, my Mom, and myself. Along with whoever else dares follow my actual entries, or gets an idea here that helps with a good entry of their own.
Cheers, Tuck |
